(2,6-Dimethylpyridin-4-yl)(4-(7-(trans-4-hydroxycydohexyl)-2-(((S)-pentan-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)piperidin-1-yl)methanone

ID: ALA4877347

Cas Number: 2226789-82-6

PubChem CID: 146403042

Product Number: U646558, Order Now?

Max Phase: Preclinical

Molecular Formula: C30H42N6O2

Molecular Weight: 518.71

Molecule Type: Unknown

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1

Standard InChI:  InChI=1S/C30H42N6O2/c1-5-6-19(2)33-30-31-17-26-27(18-36(28(26)34-30)24-7-9-25(37)10-8-24)22-11-13-35(14-12-22)29(38)23-15-20(3)32-21(4)16-23/h15-19,22,24-25,37H,5-14H2,1-4H3,(H,31,33,34)/t19-,24-,25-/m0/s1

Standard InChI Key:  MSWOWUREQODTRO-LQGLAIQGSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   13.8776  -16.1040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.8764  -16.9313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5913  -17.3442    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5895  -15.6912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3048  -16.1004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3051  -16.9268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0912  -17.1820    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5769  -16.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0908  -15.8447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3464  -17.9665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7949  -18.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0471  -19.3570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8536  -19.5325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4075  -18.9199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1550  -18.1318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1058  -20.3180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1617  -17.3433    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4475  -16.9302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7328  -17.3422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0186  -16.9291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3038  -17.3410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4482  -16.1052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3488  -15.0638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1570  -14.8936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4125  -14.1131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8632  -13.4970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0549  -13.6670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7960  -14.4532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1208  -12.7133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9283  -12.5445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5709  -12.0983    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4754  -13.1595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2822  -12.9913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5406  -12.2068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9858  -11.5904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1810  -11.7618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2408  -10.8058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8319  -13.6065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10  7  1  1
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  6
  2 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 18 22  1  6
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
  9 23  1  0
 26 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 30  1  0
 35 37  1  0
 33 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4877347

    UNC5293

Associated Targets(Human)

MERTK Tchem Proto-oncogene tyrosine-protein kinase MER (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AXL Tchem Tyrosine-protein kinase receptor UFO (3469 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYRO3 Tchem Tyrosine-protein kinase receptor TYRO3 (2906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK3 Tclin NT-3 growth factor receptor (2338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP4K4 Tchem Mitogen-activated protein kinase kinase kinase kinase 4 (2886 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TNIK Tchem TRAF2- and NCK-interacting kinase (1174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK2 Tclin Neurotrophic tyrosine kinase receptor type 2 (3279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MELK Tchem Maternal embryonic leucine zipper kinase (3491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRA Tclin Platelet-derived growth factor receptor alpha (5682 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mertk Tyrosine-protein kinase Mer (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.71Molecular Weight (Monoisotopic): 518.3369AlogP: 5.54#Rotatable Bonds: 7
Polar Surface Area: 96.17Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 5.96CX LogP: 3.66CX LogD: 3.64
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.43Np Likeness Score: -0.79

References

1. Zheng H, Zhao J, Li B, Zhang W, Stashko MA, Minson KA, Huey MG, Zhou Y, Earp HS, Kireev D, Graham DK, DeRyckere D, Frye SV, Wang X..  (2021)  UNC5293, a potent, orally available and highly MERTK-selective inhibitor.,  220  [PMID:34038857] [10.1016/j.ejmech.2021.113534]

Source